ArticleFrontiers in immunology2026
Duhuo Jisheng Decoction ameliorates experimental intervertebral disc degeneration by modulating immune-inflammatory responses through regulation of macrophage polarization.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting the nuclear factor kappa B pathway for the medical management of intervertebral disc degeneration.Frontiers in neuroscience · 2026Review
- Editorial: Macrophages at the crossroads of fibrosis and immunosuppression.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The predominant cause of lower back pain (LBP) is intervertebral disc degeneration (IVDD), which has a substantial financial cost to both individuals and society. In the pathophysiology of IVDD, the immune-inflammatory response is crucial. The number of macrophages in the nucleus pulposus (NP) was positively correlated with the degree of IVDD. The extracellular matrix (ECM) disintegration, pyroptosis, and apoptosis of nucleus pulposus cells (NPCs) have all been demonstrated to have a significant impact on IVDD and are closely linked to immune-inflammatory regulation. Meanwhile, we have shown that Duhuo Jisheng Decoction (DHJSD), which modulates the aforementioned pathways, can significantly alleviate IVDD. It's unclear, nevertheless, if DHJSD can lessen IVDD by regulating macrophage modulation of the immune-inflammatory response. Methods: In this study, we analyzed the relationship between different subtypes of macrophages and IVDD by using single-cell sequencing. Afterwards, bioinformatics techniques were employed to investigate the primary target genes in IVDD. Results: The results of Conclusion: We discovered that IVDD may be lessened by DHJSD by boosting M2 macrophage polarization and suppressing M1 macrophage polarization. IVDD responded better to DHJSD treatment in the intermediate and advanced stages of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.